Trials / Completed
CompletedNCT02506569
ProMRI 3T ENHANCED Master Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 129 (actual)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigation is designed to provide supporting evidence for the clinical safety of the Biotronik's new Implantable Cardioverter Defibrillator systems when used under specific 3 Tesla MR conditions .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable Cardioverter Defibrillator therapy | Tachycardia Fast Heart Beat |
| OTHER | Magnetic Resonance Imaging (MRI) | MRI scan of the head and lower body parts |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2018-01-15
- Completion
- 2018-01-15
- First posted
- 2015-07-23
- Last updated
- 2018-02-07
Locations
12 sites across 5 countries: Australia, Austria, Germany, Singapore, Switzerland
Source: ClinicalTrials.gov record NCT02506569. Inclusion in this directory is not an endorsement.